Home | News & Analysis
Part B News
03/15/2021
Practices must be careful about the compliance rules for coding and billing telehealth services, or they will be vulnerable to investigations and fines that could eradicate revenue.
03/15/2021
The Food and Drug Administration (FDA) recently issued an emergency use authorization (EUA) for the combination treatment of bamlanivimab and etesevimab for COVID-19 patients at high risk for severe infection.
03/15/2021
Question: We are struggling to get our providers to document whether the problems they are treating are acute, chronic or acute on chronic. I have not found a guide or publication that instructs coders what to do if this important information is missing except to query the provider. This is causing a lot of upset within our office and I’m wondering if this is one of those issues for which we should create our own internal policy for documentation?
03/15/2021
The incoming leader of the influential AMA/Specialty Society Relative Value Scale Update Committee (RUC) appears to be another sign of the AMA’s focus on digital health care.
03/15/2021
While the total number of established E/M office visit claims (99211-99215) decreased in recent years, providers still netted a payment increase because of a continued use of Levels 4 and 5 codes.
03/08/2021
Beware of new scrutiny for your annual wellness visits (AWV) and the Welcome to Medicare service one such code that usually carries a modest denial rate has shown an alarming percentage of improper payments. Make extra sure you’ve fulfilled the basics when you bill them.
03/08/2021
CMS’ new rule updating the Stark physician self-referral law brings some welcome relief for physicians who want to participate in value-based initiatives but were afraid of violating the law’s strict referral ban.
03/08/2021
As practices adapt to a new set of documentation guidelines for E/M office visits in 2021, the time is ripe to assess your risk and prevent slip-ups.
03/08/2021
Question: I diagnosed a patient with a seizure disorder. I told her to report the diagnosis to the Department of Motor Vehicles (DMV) as it may invalidate her license; I’m pretty sure she won’t do it. If I report her to the DMV myself, am I violating her confidentiality?
03/08/2021
While the volume of Welcome to Medicare visits has grown modestly and initial annual wellness visits (AWVs) have declined in recent years, the use of subsequent AWV claims has surged at a 26% growth rate.

Login

User Name:
Password:
Welcome to the new Part B News Online. If you are a returning user having trouble logging in, please click here.
Back to top